Tape over pain? study tests kinesio taping for period cramps in young athletes

NCT ID NCT06829992

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether Kinesio Taping (a special tape applied to the skin) can help reduce menstrual pain in female soccer players aged 15-17 with primary dysmenorrhea (period cramps). 50 teens from a soccer project took part, and researchers compared the real tape to a placebo version. The goal was to see if the tape lowers pain intensity and improves how pain feels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 17 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women practicing football from the Mulheres em Campo project * Primary dysmenorrhea * Aged between 15 and 17 years * Regular menstrual cycle (28 ± 7 days) * Nulliparous * Not having an intrauterine contraceptive device or using oral contraceptives * DP will be defined according to the Visual Analogue Scale from 5 points. Exclusion Criteria: * Women who do not play football in the Mulheres em Campo project * Secondary dysmenorrhea * Diagnosed with serious comorbidity * Skin lesions in the abdominal region * Allergy to adhesive tapes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary dysmenorrhea (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Gynecology of Federal University of São Paulo

    São Paulo, São Paulo, 04021-001, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.